Myopia
Not recruitingStudy on Atropine Sulfate Eye Drops to Slow Down Myopia in European Children
- Disease:Myopia
- Substances:Atropine SulfatePlacebo
Germany- Participants:0–17 years
- Substances:Atropine Sulfate
- Sponsor:Pharma Stulln GmbH
Rare diseases
Investigational molecules
Locations
Werksstrasse 3, 92551, Germany
Research activity is centered on eye health, with a clear focus on myopia in children and the clinical need to slow the worsening of nearsightedness during development.
The sponsor’s clinical interest lies in ophthalmic management strategies aimed at preserving visual function in a pediatric population.
Pharma Stulln GmbH runs clinical trials in conditions such as Myopia, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.